December 2017 december D De Dec Dece BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 0 0 no 0 10 0 0 0 0 0
1 1 1 1 1 1 1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 0 no 0 0 0 0 0 0 0
Original research original O Or Ori Orig BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 6 0 0 0 0 0
published: 22 published: p pu pub publ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 : 1 9 0 0 0 0 0
doi: 10.3389/fneur.2017.00694 doi: d do doi doi: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 :./.. 5 10 0 0 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 .. 2 10 0 0 0 0 0
Edited by: edited E Ed Edi Edit BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 : 1 4 0 0 0 0 1
J. Marc j. J J. J. J. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 ., 2 6 0 0 0 0 1
University of university U Un Uni Univ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 9 0 0 0 0 1
Baltimore, United baltimore, B Ba Bal Balt BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 , 1 10 0 0 0 0 1
Reviewed by: reviewed R Re Rev Revi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 : 1 5 0 0 0 0 1
Minjee Kim, minjee M Mi Min Minj BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 , 1 4 0 0 0 0 1
Northwestern University, northwestern N No Nor Nort BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 9 0 0 0 0 1
United States united U Un Uni Unit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 5 0 0 0 0 1
Robert F. robert R Ro Rob Robe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 0 ., 2 6 0 0 0 0 1
University of university U Un Uni Univ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 10 0 0 0 0 1
United States united U Un Uni Unit BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 5 0 0 0 0 1
*Correspondence: *Correspondence: *correspondence: * *C *Co *Cor BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 *: 2 8 0 0 0 0 1
Anke Höllig anke A An Ank Anke BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 no 0 5 0 0 0 0 1
ahoellig@ukaachen.de ahoellig@ukaachen.de ahoellig@ukaachen.de a ah aho ahoe BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 1 0 0 1 @. 2 10 0 0 0 0 1
Specialty section: specialty S Sp Spe Spec BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 : 1 7 0 0 0 0 1
This article this T Th Thi This BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 10 0 0 0 0 1
to Neurocritical to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 7 0 0 0 0 1
Neurohospitalist Care, neurohospitalist N Ne Neu Neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 , 1 8 0 0 0 0 1
a section a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 0 1 no 0 9 0 0 0 0 1
Frontiers in frontiers F Fr Fro Fron BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 8 0 0 0 0 1
Received: 20 received: R Re Rec Rece BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 : 1 8 0 0 0 0 1
Accepted: 04 accepted: A Ac Acc Acce BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 : 1 9 0 0 0 0 1
Published: 22 published: P Pu Pub Publ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 : 1 10 0 0 0 0 1
Citation: Citation: citation: C Ci Cit Cita BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 : 1 2 0 0 0 0 1
Höllig A, höllig H Hö Höl Höll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 2 ,-, 3 8 0 0 0 0 1
Clusmann H, clusmann C Cl Clu Clus BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 2 ,, 2 7 0 0 0 0 1
Schubert GA schubert S Sc Sch Schu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 2 () 2 9 0 0 0 0 1
Time Courses time T Ti Tim Time BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 no 0 8 0 0 0 0 1
Markers after markers M Ma Mar Mark BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 no 0 7 0 0 0 0 1
Subarachnoid Hemorrhage subarachnoid S Su Sub Suba BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 2 no 0 10 0 0 0 0 1
Possible Relevance possible P Po Pos Poss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 no 0 8 0 0 0 0 1
Studies. Studies. studies. S St Stu Stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 . 1 2 0 0 0 0 1
Front. Neurol. front. F Fr Fro Fron BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 ..:. 4 6 0 0 0 0 1
doi: 10.3389/fneur.2017.00694 doi: d do doi doi: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 2 :./.. 5 8 0 0 0 0 1
Time courses time T Ti Tim Time BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 3 no 0 10 0 0 0 0 1
Markers after markers M Ma Mar Mark BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 3 no 0 8 0 0 0 0 1
subarachnoid hemorrhage subarachnoid s su sub suba BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 3 no 0 9 0 0 0 0 1
Their Possible their T Th The Thei BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 3 no 0 10 0 0 0 0 1
Future studies future F Fu Fut Futu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 3 no 0 5 0 0 0 0 1
Anke Höllig anke A An Ank Anke BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 3 *,-,,, 6 10 0 0 0 0 1
Gerrit A. gerrit G Ge Ger Gerr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 3 . 1 4 0 0 0 0 1
1 Department 1 1 1 1 1 BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 1 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 4 ,,,, 4 9 0 0 0 0 1
Clinical Pharmacology, clinical C Cl Cli Clin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 ,,,,, 5 10 0 0 0 0 1
Aachen, Aachen, aachen, A Aa Aac Aach BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 4 ,, 2 1 0 0 0 0 1
Object: Aneurysmal object: O Ob Obj Obje BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 : 1 8 0 0 0 0 1
response, which response, r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 , 1 9 0 0 0 0 1
delayed cerebral delayed d de del dela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 ().,, 5 9 0 0 0 0 1
response to response r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 9 0 0 0 0 1
clinical routine clinical c cl cli clin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 ., 2 10 0 0 0 0 1
parameters after parameters p pa par para BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 ()- 3 8 0 0 0 0 1
lems of lems l le lem lems BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 no 0 9 0 0 0 0 1
deeper understanding deeper d de dee deep BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 9 0 0 0 0 1
future studies. future f fu fut futu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 . 1 1 0 0 0 0 1
Materials and materials M Ma Mat Mate BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 :, 2 9 0 0 0 0 1
initially included, initially i in ini init BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 ,.-- 4 9 0 0 0 0 1
spinal fluid spinal s sp spi spin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 (),,,,. 7 9 0 0 0 0 1
Samples were samples S Sa Sam Samp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 7 -()(- 5 9 0 0 0 0 1
ples only) ples p pl ple ples BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 )(), 4 9 0 0 0 0 1
1 (ICAM1), 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 7 (),()[() 8 10 0 0 0 0 1
samples]. Time samples]. s sa sam samp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 ]. 2 9 0 0 0 0 1
the occurrence the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 . 1 2 0 0 0 0 1
results: We results: r re res resu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 :,,,, 5 9 0 0 0 0 1
in patients' in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 9 '. 2 10 0 0 0 0 1
MMP9, ICAM1, mmp9, M MM MMP MMP9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 9 ,,., 4 9 0 0 0 0 1
difference was difference d di dif diff BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 . 1 8 0 0 0 0 1
conclusion: We conclusion: c co con conc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 : 1 8 0 0 0 0 1
interpretation and interpretation i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 ., 2 8 0 0 0 0 1
response after response r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 - 1 9 0 0 0 0 1
ies: realistic ies: i ie ies ies: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 10 : 1 10 0 0 0 0 1
the quality the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 . 1 6 0 0 0 0 1
Keywords: inflammatory keywords: K Ke Key Keyw BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 :,,,, 5 10 0 0 0 0 1
observational research observational o ob obs obse BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 11 no 0 2 0 0 0 0 1
Höllig et höllig H Hö Höl Höll BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 . 1 2 0 0 1 1 0
Time Courses time T Ti Tim Time BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 10 0 0 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 .. 2 10 0 0 1 1 0
December 2017 december D De Dec Dece BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 1 0 no 0 8 0 0 0 0 0
inTrODUcTiOn inTrODUcTiOn introduction i in inT inTr BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 10 0 0 0 0 1
Early brain early E Ea Ear Earl BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 1 0 ()- 3 8 0 0 0 0 1
orrhage (aSAH) orrhage o or orr orrh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 () 2 9 0 0 0 0 1
inflammatory parameters inflammatory i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 - 1 8 0 0 0 0 1
nal fluid nal n na nal nal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ()., 4 9 0 0 0 0 1
prognostic value prognostic p pr pro prog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 . 1 8 0 0 0 0 1
Several studies several S Se Sev Seve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
be predictive be b be be be BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 () 2 9 0 0 0 0 1
(1-8). Thus (1-8). ( (1 (1- (1-8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 (-)., 5 9 0 0 0 0 1
range, inflammatory range, r ra ran rang BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,- 2 8 0 0 0 0 1
markers to markers m ma mar mark BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
on an on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .,- 3 9 0 0 0 0 1
ous and ous o ou ous ous BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ,.., 4 10 0 0 0 0 1
compartment for compartment c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (- 2 8 0 0 0 0 1
cellular fluid-ECF-acquired cellular c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 --) 3 8 0 0 0 0 1
point for point p po poi poin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 8 0 0 0 0 1
EBI. However, ebi. E EB EBI EBI. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 ., 2 9 0 0 0 0 1
from devastating from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ., 2 8 0 0 0 0 1
inflammatory response inflammatory i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
components such components c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 8 0 0 0 0 1
glia activation glia g gl gli glia BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (), 3 8 0 0 0 0 1
(1, 8, (1, ( (1 (1, (1, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 (,,),-(), 9 9 0 0 0 0 1
modulation of modulation m mo mod modu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (). 3 9 0 0 0 0 1
immunoreaction is immunoreaction i im imm immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 .- 2 8 0 0 0 0 1
matory activation, matory m ma mat mato BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 , 1 9 0 0 0 0 1
reactions, which reactions, r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,;- 3 9 0 0 0 0 1
bosis, cortical bosis, b bo bos bosi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ,,, 3 8 0 0 0 0 1
and blood-brain and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -, 2 8 0 0 0 0 1
dysfunction of dysfunction d dy dys dysf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ()., 4 9 0 0 0 0 1
microcirculatory dysfunction microcirculatory m mi mic micr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
activation. Thus, activation. a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ., 2 9 0 0 0 0 1
hamper the hamper h ha ham hamp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 '. 2 9 0 0 0 0 1
There is there T Th The Ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 0 0 0 0 1
after aSAH after a af aft afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 9 0 0 0 0 1
However, none however, H Ho How Howe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 8 0 0 0 0 1
into clinical into i in int into BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .- 2 9 0 0 0 0 1
tioned enormous tioned t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
low specificity low l lo low low BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 0 ., 2 9 0 0 0 0 1
we present we w we we we BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 0 0 0 0 1
to illustrate to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
after aSAH. after a af aft afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 8 0 0 0 0 1
parameters during parameters p pa par para BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
an individual an a an an an BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 0 (.., 4 9 0 0 0 0 1
of DCI). of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 )., 3 8 0 0 0 0 1
of parameters of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 8 0 0 0 0 1
physiological reaction physiological p ph phy phys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 9 0 0 0 0 1
the pro-inflammatory the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 9 0 0 0 0 1
may possibly may m ma may may BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 1 0 0 1 0 - 1 9 0 0 0 0 1
therapeutic approaches. therapeutic t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 3 0 0 0 0 1
Taken together, taken T Ta Tak Take BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 , 1 8 0 0 0 0 1
risk estimation risk r ri ris risk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
inflammatory biomarkers inflammatory i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ., 2 9 0 0 0 0 1
a multicenter a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 1 0 no 0 10 0 0 0 0 1
inflammatory parameters inflammatory i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
the pathophysiology the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 4 0 0 0 0 1
MaTerials anD materials M Ma MaT MaTe BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 10 0 0 0 0 1
The prospective the T Th The The BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 9 0 0 0 0 1
committee (Ethikkommission committee c co com comm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 ( 1 8 0 0 0 0 1
der Rheinischen der d de der der BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 --, 3 7 0 0 0 0 1
Germany; EK germany; G Ge Ger Germ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 6 ;/), 4 8 0 0 0 0 1
the Declaration the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 9 0 0 0 0 1
representatives. Data representatives. r re rep repr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 . 1 9 0 0 0 0 1
elsewhere (8, elsewhere e el els else BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 (,,). 5 9 0 0 0 0 1
aSAH were asah a aS aSA aSAH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 -. 2 9 0 0 0 0 1
Patients were patients P Pa Pat Pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 , 1 9 0 0 0 0 1
enrolled in enrolled e en enr enro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 , 1 9 0 0 0 0 1
onset or onset o on ons onse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 . 1 9 0 0 0 0 1
criteria, 28 criteria, c cr cri crit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 ,( 2 10 0 0 0 0 1
or data or o or or or BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 ,, 2 10 0 0 0 0 1
in another in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 6 ).,,- 5 9 0 0 0 0 1
tory, and tory, t to tor tory BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 ,. 2 9 0 0 0 0 1
Inflammatory parameters inflammatory I In Inf Infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 6 no 0 8 0 0 0 0 1
days 1, days d da day days BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 ,,,,. 5 9 0 0 0 0 1
with necessity with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 8 0 0 0 0 1
(n = (n ( (n (n (n BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 (). 3 9 0 0 0 0 1
routine diagnostic routine r ro rou rout BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 (::..). 7 7 0 0 0 0 1
sample Processing sample s sa sam samp BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
Blood and blood B Bl Blo Bloo BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 , 1 9 0 0 0 0 1
before processing. before b be bef befo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 . 1 9 0 0 0 0 1
of Clinical of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 , 1 9 0 0 0 0 1
of Bonn, of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 ,[ 2 10 0 0 0 0 1
(G/L), determination (g/l), ( (G (G/ (G/L BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 (/),-(,/), 10 9 0 0 0 0 1
interleukin 6 interleukin i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 (,/)], 6 9 0 0 0 0 1
enzyme-linked immunofluorescence enzyme-linked e en enz enzy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 - 1 9 0 0 0 0 1
matrix metallopeptidase matrix m ma mat matr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 (,/),- 6 9 0 0 0 0 1
sion molecule sion s si sio sion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 (,/),- 6 9 0 0 0 0 1
tor (LIF, tor t to tor tor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 (,/)( 5 9 0 0 0 0 1
International GmbH, international I In Int Inte BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 ,,). 4 6 0 0 0 0 1
analysis analysis analysis a an ana anal BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 10 0 0 0 0 1
Courses of courses C Co Cou Cour BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 (),- 4 9 0 0 0 0 1
ally CSF ally a al all ally BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 9 no 0 9 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 9 0 0 0 0 1
time of time t ti tim time BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 . 1 8 0 0 0 0 1
GraphPad Prism graphpad G Gr Gra Grap BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 ., 2 9 0 0 0 0 1
the Mann-Whitney the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 -. 2 8 0 0 0 0 1
grouping variable grouping g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 9 0 0 0 0 1
a biomarker a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 3 9 ., 2 9 0 0 0 0 1
was defined was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 ( 1 9 0 0 0 0 1
modified National modified m mo mod modi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 ). 2 9 0 0 0 0 1
Furthermore, clinical furthermore, F Fu Fur Furt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 , 1 9 0 0 0 0 1
and new and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 9 0 0 0 0 1
cranial computed cranial c cr cra cran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 9 no 0 8 0 0 0 0 1
(in case (in ( (i (in (in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 9 ( 1 9 0 0 0 0 1
deficit) were deficit) d de def defi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 9 )( 2 9 0 0 0 0 1
other causes other o ot oth othe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 ). 2 8 0 0 0 0 1
relevant known relevant r re rel rele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 ,,, 3 10 0 0 0 0 1
or electrolyte or o or or or BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 9 0 0 0 0 1
of DCI. of o of of of BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 .. 2 7 0 0 0 0 1
FigUre | figure F Fi Fig FigU BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 ()()[();],[();], 16 10 0 0 0 0 1
and all and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 [();]. 6 9 0 0 0 0 1
Wilcoxon Rank wilcoxon W Wi Wil Wilc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 ::.:.;:.:.. 11 5 0 0 0 0 1
FigUre 2 figure F Fi Fig FigU BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 1 ()()[();], 10 9 0 0 0 0 1
samples [(B); samples s sa sam samp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 1 [();],[();]. 12 10 0 0 0 0 1
and peak and a an and and BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 ::.:.;:.:.. 11 8 0 0 0 0 1
3 3 3 3 3 3 3 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 2 no 0 10 0 0 0 0 0
Höllig et höllig H Hö Höl Höll BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 3 . 1 2 0 0 0 0 0
Time Courses time T Ti Tim Time BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 3 no 0 10 0 0 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 3 .. 2 10 0 0 0 0 0
December 2017 december D De Dec Dece BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 3 3 no 0 8 0 0 0 0 0
resUlTs resUlTs results r re res resU BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 3 no 0 10 0 0 0 0 1
Baseline characteristics baseline B Ba Bas Base BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 3 no 0 10 0 0 0 0 1
supplemental data supplemental s su sup supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 (). 3 10 0 0 0 0 1
Infectious complications infectious I In Inf Infe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 3 (.) 3 9 0 0 0 0 1
day 1, day d da day day BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 3 ,(.),(.), 9 9 0 0 0 0 1
(44.4%) at (44.4%) ( (4 (44 (44. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 (.),(.). 8 7 0 0 0 0 1
interleukin 6 interleukin i in int inte BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 4 no 0 10 0 0 0 0 1
Serum course serum S Se Ser Seru BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 4 no 0 9 0 0 0 0 1
samples (Figures samples s sa sam samp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 4 (,). 4 9 0 0 0 0 1
represents values represents r re rep repr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 , 1 9 0 0 0 0 1
of IL6 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 ()(). 5 9 0 0 0 0 1
values are values v va val valu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 (-)., 5 10 0 0 0 0 1
confidence intervals confidence c co con conf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 no 0 9 0 0 0 0 1
the enormous the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 . 1 7 0 0 0 0 1
Matrix Metallopeptidase matrix M Ma Mat Matr BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 6 no 0 10 0 0 0 0 1
Matrix metallopeptidase matrix M Ma Mat Matr BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 6 () 2 10 0 0 0 0 1
than in than t th tha than BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 ()()., 6 9 0 0 0 0 1
MMP9 is mmp9 M MM MMP MMP9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 ' 1 9 0 0 0 0 1
then in then t th the then BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 . 1 1 0 0 0 0 1
intercellular adhesion intercellular i in int inte BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 7 no 0 10 0 0 0 0 1
Intercellular adhesion intercellular I In Int Inte BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 7 no 0 9 0 0 0 0 1
acquired serum acquired a ac acq acqu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 ., 2 10 0 0 0 0 1
(6.3 ng/mL) (6.3 ( (6 (6. (6.3 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 7 (./).(). 8 9 0 0 0 0 1
Highest value highest H Hi Hig High BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 7 ./., 4 9 0 0 0 0 1
the peak the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 (). 3 10 0 0 0 0 1
However, variability however, H Ho How Howe BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 7 ,. 2 9 0 0 0 0 1
leukemia inhibitory leukemia l le leu leuk BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 8 no 0 10 0 0 0 0 1
Leukemia inhibitory leukemia L Le Leu Leuk BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 8 ' 1 10 0 0 0 0 1
samples (LOD: samples s sa sam samp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 8 (:./). 6 9 0 0 0 0 1
differs a differs d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 (): 3 9 0 0 0 0 1
in CSF, in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 8 , 1 9 0 0 0 0 1
(Figure 4A). (figure ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 8 (). 3 8 0 0 0 0 1
demonstrated by demonstrated d de dem demo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 .( 2 9 0 0 0 0 1
to 10-fold) to t to to to BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 -)(,). 6 4 0 0 0 0 1
crP and crp c cr crP crP BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 9 no 0 10 0 0 0 0 1
The levels the T Th The The BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 10 no 0 8 0 0 0 0 1
serum samples. serum s se ser seru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 ., 2 9 0 0 0 0 1
almost inversely. almost a al alm almo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 .(), 4 10 0 0 0 0 1
whereas leukocyte whereas w wh whe wher BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 (). 3 7 0 0 0 0 1
courses of courses c co cou cour BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 no 0 10 0 0 0 0 1
related to related r re rel rela BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 no 0 4 0 0 0 0 1
In 18 in I In In In BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 4 11 (.),(: 6 8 0 0 0 0 1
n = n n n n n BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 4 11 ;:;:;:;:;: 10 10 0 0 0 0 1
n = n n n n n BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 4 11 ). 2 9 0 0 0 0 1
FigUre 5 figure F Fi Fig FigU BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 -()[();] 8 9 0 0 0 0 1
available [(B); available a av ava avai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 [();].:: 8 10 0 0 0 0 1
day 1 day d da day day BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 0 .:.. 4 1 0 0 0 0 1
FigUre 4 figure F Fi Fig FigU BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 2 ()()[();], 10 9 0 0 0 0 1
[(B); LIFserum], [(b); [ [( [(B [(B) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 2 [();],[();]. 12 10 0 0 0 0 1
assessed via assessed a as ass asse BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 ::.:.;:.:.. 11 6 0 0 0 0 1
FigUre 3 figure F Fi Fig FigU BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 5 ()()[();], 10 10 0 0 0 0 1
samples [(B); samples s sa sam samp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 5 [();],[();]. 12 9 0 0 0 0 1
peak values peak p pe pea peak BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 5 ::.:.;:.:.. 11 7 0 0 0 0 1
4 4 4 4 4 4 4 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 8 no 0 10 0 0 0 0 0
Höllig et höllig H Hö Höl Höll BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 8 . 1 2 0 0 0 0 0
Time Courses time T Ti Tim Time BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 10 0 0 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 9 .. 2 10 0 0 0 0 0
December 2017 december D De Dec Dece BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 5 9 no 0 8 0 0 0 0 0
to occurrence to t to to to BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 , 1 10 0 0 0 0 1
(Mann-Whitney U (mann-whitney ( (M (Ma (Man BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 9 (-). 4 10 0 0 0 0 1
leukocyte count leukocyte l le leu leuk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 9 (.). 4 9 0 0 0 0 1
Figure 7. figure F Fi Fig Figu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 9 . 1 1 0 0 0 0 1
courses of courses c co cou cour BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 no 0 10 0 0 0 0 1
related to related r re rel rela BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 no 0 8 0 0 0 0 1
Courses of courses C Co Cou Cour BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 no 0 8 0 0 0 0 1
related to related r re rel rela BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 11 . 1 10 0 0 0 0 1
FigUre | figure F Fi Fig FigU BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 [();] 5 9 0 0 0 0 1
available [(B); available a av ava avai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 [();]. 6 10 0 0 0 0 1
Test: leukocyte test: T Te Tes Test BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 ::.:.. 6 3 0 0 0 0 1
FigUre 7 figure F Fi Fig FigU BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 6 ()(). 5 10 0 0 0 0 1
5 5 5 5 5 5 5 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 8 no 0 10 0 0 0 0 0
Höllig et höllig H Hö Höl Höll BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 9 . 1 2 0 0 0 0 0
Time Courses time T Ti Tim Time BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 9 no 0 10 0 0 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 10 .. 2 10 0 0 1 0 0
December 2017 december D De Dec Dece BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 5 10 no 0 8 0 0 0 0 0
FigUre 8 figure F Fi Fig FigU BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 (). 3 10 0 0 0 0 1
6 6 6 6 6 6 6 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 0 no 0 10 0 0 0 0 0
Höllig et höllig H Hö Höl Höll BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 . 1 2 0 0 0 0 0
Time Courses time T Ti Tim Time BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 10 0 0 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 .. 2 10 0 0 0 0 0
December 2017 december D De Dec Dece BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 5 0 no 0 8 0 0 0 0 0
was available was w wa was was BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 [:(.);: 7 9 0 0 0 0 1
n = n n n n n BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 5 1 ();:(.);:(.)]. 14 10 0 0 0 0 1
For statistical for F Fo For For BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 1 ,- 2 9 0 0 0 0 1
ing to ing i in ing ing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 5 1 (:;: 4 9 0 0 0 0 1
and 4). and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 ).: 3 9 0 0 0 0 1
the measured the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 no 0 9 0 0 0 0 1
Fisher scale fisher F Fi Fis Fish BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 5 1 (.),(.), 8 9 0 0 0 0 1
(p = (p ( (p (p (p BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 1 (.;-). 6 8 0 0 0 0 1
also seen also a al als also BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 (.)(.), 7 9 0 0 0 0 1
further for further f fu fur furt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 (.;-). 6 9 0 0 0 0 1
All courses all A Al All All BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 1 . 1 5 0 0 0 0 1
courses of courses c co cou cour BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 no 0 10 0 0 0 0 1
related to related r re rel rela BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 no 0 8 0 0 0 0 1
Courses of courses C Co Cou Cour BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 5 no 0 10 0 0 0 0 1
to the to t to to to BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 no 0 9 0 0 0 0 1
scale score, scale s sc sca scal BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 ,. 2 9 0 0 0 0 1
for n for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 [:(.);: 7 9 0 0 0 0 1
(18.5%); WFNS (18.5%); ( (1 (18 (18. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 (.);:(.);:(.); 14 9 0 0 0 0 1
5: n 5: 5 5: 5: 5: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 :(.)]., 7 9 0 0 0 0 1
for statistical for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 (:-;: 5 8 0 0 0 0 1
4 and 4 4 4 4 4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 6 ). 2 10 0 0 0 0 1
impact of impact i im imp impa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 : 1 9 0 0 0 0 1
significant differences significant s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 . 1 9 0 0 0 0 1
group were group g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 (.);(.); 8 10 0 0 0 0 1
(p = (p ( (p (p (p BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 (.),(.;-). 10 9 0 0 0 0 1
day 1 day d da day day BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 6 , 1 9 0 0 0 0 1
than in than t th tha than BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 , 1 9 0 0 0 0 1
mean values mean m me mea mean BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 . 1 8 0 0 0 0 1
Levels of levels L Le Lev Leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 6 no 0 9 0 0 0 0 1
were found were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 : 1 9 0 0 0 0 1
significantly higher significantly s si sig sign BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 no 0 8 0 0 0 0 1
FigUre | figure F Fi Fig FigU BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 (). 3 10 0 0 0 0 1
7 7 7 7 7 7 7 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 0 no 0 10 0 0 0 0 0
Höllig et höllig H Hö Höl Höll BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 . 1 2 0 0 0 0 0
Time Courses time T Ti Tim Time BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 10 0 0 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 1 .. 2 10 0 0 0 0 0
December 2017 december D De Dec Dece BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 6 1 no 0 8 0 0 0 0 0
compared with compared c co com comp BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 (:.;: 5 9 0 0 0 0 1
p = p p p p p BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 6 1 .;-). 5 5 0 0 0 0 1
No significant no N No No No BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 10 0 0 0 0 1
score were score s sc sco scor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 ,,,. 4 9 0 0 0 0 1
All courses all A Al All All BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 1 . 1 6 0 0 0 0 1
DiscUssiOn DiscUssiOn discussion D Di Dis Disc BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 3 no 0 10 0 0 0 0 1
Here, we here, H He Her Here BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 3 ,- 2 9 0 0 0 0 1
meters (IL6, meters m me met mete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 (,,,) 5 9 0 0 0 0 1
after aSAH, after a af aft afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 , 1 10 0 0 0 0 1
serum. The serum. s se ser seru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 . 1 10 0 0 0 0 1
than in than t th tha than BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 , 1 9 0 0 0 0 1
whereas MMP9 whereas w wh whe wher BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 - 1 9 0 0 0 0 1
tions in tions t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 3 . 1 10 0 0 0 0 1
nearly act nearly n ne nea near BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 . 1 3 0 0 0 0 1
Our evaluation our O Ou Our Our BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 6 - 1 8 0 0 0 0 1
rence of rence r re ren renc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 6 no 0 9 0 0 0 0 1
the measured the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 no 0 9 0 0 0 0 1
biomarker. However, biomarker. b bi bio biom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 6 ., 2 8 0 0 0 0 1
after aSAH after a af aft afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 - 1 9 0 0 0 0 1
ies: realistic ies: i ie ies ies: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 6 : 1 10 0 0 0 0 1
database will database d da dat data BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 no 0 9 0 0 0 0 1
acquired results. acquired a ac acq acqu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 . 1 2 0 0 0 0 1
Interleukin 6 interleukin I In Int Inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 . 1 9 0 0 0 0 1
by various by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 (,, 3 9 0 0 0 0 1
causes of causes c ca cau caus BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 ,, 2 8 0 0 0 0 1
e.g., depression e.g., e e. e.g e.g. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 6 ..,).- 6 9 0 0 0 0 1
tions dealing tions t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 6 no 0 9 0 0 0 0 1
outcome and outcome o ou out outc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 (,,,,,-). 9 8 0 0 0 0 1
courses of courses c co cou cour BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 no 0 9 0 0 0 0 1
those illustrated those t th tho thos BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 (),, 4 9 0 0 0 0 1
Höllig et höllig H Hö Höl Höll BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 . 1 2 0 0 1 0 0
Time Courses time T Ti Tim Time BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 10 0 0 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 .. 2 10 0 0 1 0 0
December 2017 december D De Dec Dece BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 7 0 no 0 8 0 0 0 0 0
demonstrate a demonstrate d de dem demo BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 (,)., 5 9 0 0 0 0 1
acquisition differ acquisition a ac acq acqu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ; 1 9 0 0 0 0 1
thus, comparison thus, t th thu thus BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,., 3 9 0 0 0 0 1
ranges of ranges r ra ran rang BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ., 2 10 0 0 0 0 1
to WFNS to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 9 0 0 0 0 1
injury's severity injury's i in inj inju BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 '., 3 9 0 0 0 0 1
biomarker is biomarker b bi bio biom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 - 1 9 0 0 0 0 1
effect showing effect e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 - 1 9 0 0 0 0 1
regenerative aspects. regenerative r re reg rege BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 . 1 3 0 0 0 0 1
Higher levels higher H Hi Hig High BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 - 1 7 0 0 0 0 1
vorable outcome vorable v vo vor vora BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ().,(.., 8 9 0 0 0 0 1
measured values) measured m me mea meas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ), 2 8 0 0 0 0 1
than 10-fold than t th tha than BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 -. 2 5 0 0 0 0 1
The interpretation the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 8 0 0 0 0 1
the LOD the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,. 2 9 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 9 0 0 0 0 1
lower than lower l lo low lowe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 (), 3 9 0 0 0 0 1
levels are levels l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ., 2 9 0 0 0 0 1
possible due possible p po pos poss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 9 0 0 0 0 1
and colleagues and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 8 0 0 0 0 1
time after time t ti tim time BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ().;, 5 9 0 0 0 0 1
serum levels serum s se ser seru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 6 0 0 0 0 1
There are there T Th The Ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 8 0 0 0 0 1
an early an a an an an BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 0 no 0 9 0 0 0 0 1
in serum in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 0 . 1 2 0 0 0 0 1
Leukocyte count leukocyte L Le Leu Leuk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 no 0 8 0 0 0 0 1
prognosis as prognosis p pr pro prog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 (,,-). 6 9 0 0 0 0 1
parameters are parameters p pa par para BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 - 1 8 0 0 0 0 1
ers. Anyway, ers. e er ers ers. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ., 2 9 0 0 0 0 1
of disease of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 5 0 0 0 0 1
We present we W We We We BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 7 0 0 0 0 1
parameters after parameters p pa par para BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 8 0 0 0 0 1
by the by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 9 0 0 0 0 1
Furthermore, sample furthermore, F Fu Fur Furt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 ,. 2 8 0 0 0 0 1
However, we however, H Ho How Howe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 ,- 2 8 0 0 0 0 1
stand the stand s st sta stan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 7 0 0 0 0 1
Due to due D Du Due Due BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 8 0 0 0 0 1
range, inflammatory range, r ra ran rang BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,. 2 8 0 0 0 0 1
Nevertheless, there nevertheless, N Ne Nev Neve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 , 1 8 0 0 0 0 1
aSAH, which asah, a aS aSA aSAH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 , 1 9 0 0 0 0 1
with each with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 9 0 0 0 0 1
from the from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 9 0 0 0 0 1
are poorly are a ar are are BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ., 2 8 0 0 0 0 1
that further that t th tha that BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 no 0 9 0 0 0 0 1
inflammatory reaction inflammatory i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 no 0 9 0 0 0 0 1
with outcome with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 no 0 9 0 0 0 0 1
promising. Generally, promising. p pr pro prom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 ., 2 9 0 0 0 0 1
illustrate and illustrate i il ill illu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 no 0 9 0 0 0 0 1
aSAH has asah a aS aSA aSAH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 no 0 8 0 0 0 0 1
biomarker resulting biomarker b bi bio biom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 ,. 2 10 0 0 0 0 1
Furthermore, these furthermore, F Fu Fur Furt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 5 , 1 8 0 0 0 0 1
studies' realistic studies' s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 '- 2 10 0 0 0 0 1
evant and evant e ev eva evan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 ., 2 9 0 0 0 0 1
in research in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 5 no 0 9 0 0 0 0 1
networks to networks n ne net netw BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 5 . 1 4 0 0 0 0 1
eThics sTaTeMenT ethics e eT eTh eThi BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 no 0 10 0 0 0 0 1
This study this T Th Thi This BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 6 - 1 9 0 0 0 0 1
tions of tions t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 " 1 9 0 0 0 0 1
Rheinischen Friedrich-Wilhelms rheinischen R Rh Rhe Rhei BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 - 1 8 0 0 0 0 1
guidelines, name guidelines, g gu gui guid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ," 2 9 0 0 0 0 1
from all from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 . 1 10 0 0 0 0 1
accordance with accordance a ac acc acco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 . 1 9 0 0 0 0 1
approved by approved a ap app appr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 ( 1 9 0 0 0 0 1
Medizinischen Fakultät medizinischen M Me Med Medi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 -- 2 8 0 0 0 0 1
Universität Bonn, universität U Un Uni Univ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,;/). 5 6 0 0 0 0 1
aUThOr cOnTriBUTiOns author a aU aUT aUTh BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 no 0 10 0 0 0 0 1
AH conceived ah A AH AH AH BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 7 ,, 2 8 0 0 0 0 1
preliminary draft. preliminary p pr pre prel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 .- 2 8 0 0 0 0 1
of serum of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 ;. 2 9 0 0 0 0 1
MV and mv M MV MV MV BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 7 no 0 8 0 0 0 0 1
the manuscript. the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 . 1 9 0 0 0 0 1
revision of revision r re rev revi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 . 1 9 0 0 0 0 1
the study the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 . 1 9 0 0 0 0 1
All the all A Al All All BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 7 ,,. 3 10 0 0 0 0 1
sUPPleMenTarY MaTerial supplementary s sU sUP sUPP BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 no 0 10 0 0 0 0 1
The Supplementary the T Th The The BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 8 no 0 9 0 0 0 0 1
at http://www.frontiersin.org/articles/10.3389/fneur.2017.00694/ at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 ://..//./../ 12 10 0 0 0 0 1
full#supplementary-material. full#supplementary-material. full#supplementary-material. f fu ful full BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 8 #-. 3 4 0 0 0 0 1
TaBle s1 table T Ta TaB TaBl BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 8 . 1 10 0 0 0 0 1
reFerences reFerences references r re reF reFe BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 no 0 10 0 0 0 0 1
1. Mathiesen 1. 1 1. 1. 1. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 8 .,,,.- 6 10 0 0 0 0 1
levels in levels l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 . 1 9 0 0 0 0 1
(1993) 78(4):562-7. (1993) ( (1 (19 (199 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 8 ()():-.:./.... 14 6 0 0 0 0 1
2. Muroi 2. 2 2. 2. 2. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 8 .,,,,,,. 8 9 0 0 0 0 1
Correlation among correlation C Co Cor Corr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 8 , 1 8 0 0 0 0 1
delayed neurological delayed d de del dela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 , 1 9 0 0 0 0 1
hemorrhage. Neurosurgery hemorrhage. h he hem hemo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 .()():-;.:./ 12 9 0 0 0 0 1
NEU.0b013e31828048ce NEU.0b013e31828048ce neu.0b013e31828048ce N NE NEU NEU. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 8 . 1 2 0 0 0 0 1
3. Rothoerl 3. 3 3. 3. 3. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 8 .,,,,. 6 9 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 - 1 9 0 0 0 0 1
of cerebral of o of of of BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 . 1 8 0 0 0 0 1
J Neurosurg j J J J J BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 10 ()():-.:./... 13 9 0 0 0 0 1
30750.af 30750.af 30750.af 3 30 307 3075 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 . 1 1 0 0 0 0 1
4. Tanriverdi 4. 4 4. 4. 4. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 .,,,,,,. 8 10 0 0 0 0 1
cerebrospinal fluid cerebrospinal c ce cer cere BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 10 - 1 9 0 0 0 0 1
subarachnoid hemorrhage. subarachnoid s su sub suba BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 10 .()():-. 8 8 0 0 0 0 1
5. Jeon 5. 5 5. 5. 5. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 .,,,,,,. 8 9 0 0 0 0 1
C-reactive protein c-reactive C C- C-r C-re BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 10 - 1 9 0 0 0 0 1
and symptomatic and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 10 no 0 8 0 0 0 0 1
hemorrhage. J hemorrhage. h he hem hemo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 10 .()():-.:./. 12 9 0 0 0 0 1
0b013e31826047a2 0b013e31826047a2 0b013e31826047a2 0 0b 0b0 0b01 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 10 no 0 2 0 0 0 0 1
6. Triglia 6. 6 6. 6. 6. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 .,,,,,,. 8 9 0 0 0 0 1
Early matrix early E Ea Ear Earl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 1 1 0 0 0 0 0 9 10 -- 2 9 0 0 0 0 1
rysmal subarachnoid rysmal r ry rys rysm BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 10 : 1 8 0 0 0 0 1
9 9 9 9 9 9 9 BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 9 0 no 0 10 0 0 0 0 0
Höllig et höllig H Hö Höl Höll BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 . 1 2 0 0 1 0 0
Time Courses time T Ti Tim Time BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 10 0 0 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 .. 2 10 0 0 0 0 0
December 2017 december D De Dec Dece BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 9 0 no 0 8 0 0 0 0 0
an observational an a an an an BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 0 .()():-.:./ 11 9 0 0 0 0 1
EJA.0000000000000494 EJA.0000000000000494 eja.0000000000000494 E EJ EJA EJA. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 . 1 2 0 0 0 0 1
7. McGirt 7. 7 7. 7. 7. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,,,. 7 9 0 0 0 0 1
Serum von serum S Se Ser Seru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 ,-, 3 8 0 0 0 0 1
endothelial growth endothelial e en end endo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 no 0 9 0 0 0 0 1
aneurysmal subarachnoid aneurysmal a an ane aneu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 .()():-; 8 8 0 0 0 0 1
discussion 1134-25. discussion d di dis disc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 -.:./-- 7 7 0 0 0 0 1
8. Hollig 8. 8 8. 8. 8. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,-,,, 7 8 0 0 0 0 1
Clusmann H. clusmann C Cl Clu Clus BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 .- 2 9 0 0 0 0 1
noid hemorrhage noid n no noi noid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 :. 2 9 0 0 0 0 1
Neurol Neurosurg neurol N Ne Neu Neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ():-.:./.... 12 8 0 0 0 0 1
9. Schneider 9. 9 9. 9. 9. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,,,,. 8 9 0 0 0 0 1
Microglia inflict microglia M Mi Mic Micr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 . 1 9 0 0 0 0 1
Neuropathol (2015) neuropathol N Ne Neu Neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ()():-.:./--- 13 8 0 0 0 0 1
10. Niwa 10. 1 10 10. 10. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,,,.-, 9 9 0 0 0 0 1
MCP-1, IP-10, mcp-1, M MC MCP MCP- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 -,-, 4 9 0 0 0 0 1
after subarachnoid after a af aft afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .()():. 7 8 0 0 0 0 1
doi:10.1186/s12974-016-0675-7 doi:10.1186/s12974-016-0675-7 doi:10.1186/s12974-016-0675-7 d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 :./--- 6 3 0 0 0 0 1
11. Chaichana 11. 1 11 11. 11. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,. 5 9 0 0 0 0 1
(leukocyte-endothelial cell (leukocyte-endothelial ( (l (le (leu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 (-)- 4 8 0 0 0 0 1
noid hemorrhage. noid n no noi noid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 .()():-.:./. 12 8 0 0 0 0 1
surneu.2009.05.027 surneu.2009.05.027 surneu.2009.05.027 s su sur surn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 ... 3 2 0 0 0 0 1
12. Hanafy 12. 1 12 12. 12. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .. 2 10 0 0 0 0 1
and vasospasm and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .() 3 9 0 0 0 0 1
10:83. doi:10.1186/1742-2094-10-83 10:83. 1 10 10: 10:8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 :.:./--- 8 4 0 0 0 0 1
13. Terpolilli 13. 1 13 13. 13. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,. 5 9 0 0 0 0 1
vessels? Cerebral vessels? v ve ves vess BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 ?. 2 9 0 0 0 0 1
(2015) 46(10):3014-9. (2015) ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 ()():-.:./.. 12 6 0 0 0 0 1
14. Chamling 14. 1 14 14. 14. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,-,,, 7 8 0 0 0 0 1
Coburn M, coburn C Co Cob Cobu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 9 0 ,.: 3 9 0 0 0 0 1
relevance for relevance r re rel rele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ? 1 9 0 0 0 0 1
Neurosurg (2017) neurosurg N Ne Neu Neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ():-.:./.... 12 7 0 0 0 0 1
15. Hollig 15. 1 15 15. 15. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,-,,. 7 9 0 0 0 0 1
properties of properties p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 - 1 8 0 0 0 0 1
interleukin 6 interleukin i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 : 1 8 0 0 0 0 1
cohort study. cohort c co coh coho BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 .():.:./--- 11 8 0 0 0 0 1
16. McMahon 16. 1 16 16. 16. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,,,,. 8 9 0 0 0 0 1
Inflammation as inflammation I In Inf Infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 9 0 0 0 0 1
subarachnoid haemorrhage. subarachnoid s su sub suba BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 .()():-.:./ 11 9 0 0 0 0 1
neurintsurg-2012-010386 neurintsurg-2012-010386 neurintsurg-2012-010386 n ne neu neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 -- 2 3 0 0 0 0 1
17. Lenski 17. 1 17 17. 17. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,,,. 7 9 0 0 0 0 1
the cerebrospinal the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 10 0 0 0 0 1
after severe after a af aft afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .():-. 6 8 0 0 0 0 1
doi:10.1016/j.wneu.2016.11.131 doi:10.1016/j.wneu.2016.11.131 doi:10.1016/j.wneu.2016.11.131 d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 :./.... 7 3 0 0 0 0 1
18. Kao 18. 1 18 18. 18. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,,,,.- 9 9 0 0 0 0 1
as a as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 8 0 0 0 0 1
(2015) 10(7):e0132115. (2015) ( (2 (20 (201 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 ()():.:./.. 11 7 0 0 0 0 1
19. Nakahara 19. 1 19 19. 19. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 .,,,,,,. 8 9 0 0 0 0 1
High-mobility group high-mobility H Hi Hig High BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 -- 2 8 0 0 0 0 1
orrhage. Neurocrit orrhage. o or orr orrh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 6 .()():-.:./--- 14 8 0 0 0 0 1
20. Fassbender 20. 2 20 20. 20. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 .,,,,,,. 8 9 0 0 0 0 1
Inflammatory cytokines inflammatory I In Inf Infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 : 1 8 0 0 0 0 1
abnormal blood abnormal a ab abn abno BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 . 1 9 0 0 0 0 1
Psychiatry (2001) psychiatry P Ps Psy Psyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 ()():-.:./... 13 6 0 0 0 0 1
21. Chou 21. 2 21 21. 21. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 .,,,,,, 7 8 0 0 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 6 .- 2 9 0 0 0 0 1
markers of markers m ma mar mark BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 . 1 8 0 0 0 0 1
Stroke Res stroke S St Str Stro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 ()():-.:./--- 13 7 0 0 0 0 1
22. Kaynar 22. 2 22 22. 22. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 .,,,,,,. 8 8 0 0 0 0 1
Detection of detection D De Det Dete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 - 1 8 0 0 0 0 1
adhesion molecule-1 adhesion a ad adh adhe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 - 1 9 0 0 0 0 1
aneurysmal subarachnoid aneurysmal a an ane aneu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 6 .()():-. 8 8 0 0 0 0 1
doi:10.3171/jns.2004.101.6.1030 doi:10.3171/jns.2004.101.6.1030 doi:10.3171/jns.2004.101.6.1030 d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 6 :./.... 7 3 0 0 0 0 1
23. Mack 23. 2 23 23. 23. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 .,,,,,,. 8 9 0 0 0 0 1
prediction with prediction p pr pre pred BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 -- 2 9 0 0 0 0 1
mal subarachnoid mal m ma mal mal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 6 .()():-.:./ 11 8 0 0 0 0 1
jns.2002.96.1.0071 jns.2002.96.1.0071 jns.2002.96.1.0071 j jn jns jns. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 6 .... 4 2 0 0 0 0 1
24. Juvela 24. 2 24 24. 24. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 .,,.- 5 9 0 0 0 0 1
outcome after outcome o ou out outc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 . 1 7 0 0 0 0 1
(2012) 154(3):397-404. (2012) ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 6 ()():-.:./--- 13 6 0 0 0 0 1
25. Badjatia 25. 2 25 25. 25. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 .,,,,,, 7 9 0 0 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 6 .-,, 4 9 0 0 0 0 1
and delayed and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 . 1 8 0 0 0 0 1
Stroke (2011) stroke S St Str Stro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 6 ()():-.:./.. 12 7 0 0 0 0 1
26. Srinivasan 26. 2 26 26. 26. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 .,,,,, 6 8 0 0 0 0 1
Singh H, singh S Si Sin Sing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 6 ,.- 3 8 0 0 0 0 1
C-reactive protein c-reactive C C- C-r C-re BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 - 1 9 0 0 0 0 1
subarachnoid hemorrhage. subarachnoid s su sub suba BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 6 .():-.:./. 10 8 0 0 0 0 1
wneu.2016.02.049 wneu.2016.02.049 wneu.2016.02.049 w wn wne wneu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 6 ... 3 2 0 0 0 0 1
27. Kasius 27. 2 27 27. 27. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 .,,,. 5 10 0 0 0 0 1
counts with counts c co cou coun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 10 6 - 1 8 0 0 0 0 1
rhage. Cerebrovasc rhage. r rh rha rhag BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 6 .()():-.:./ 11 7 0 0 0 0 1
Conflict of conflict C Co Con Conf BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 10 :- 2 9 0 0 0 0 1
ducted in ducted d du duc duct BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 10 no 0 10 0 0 0 0 1
construed as construed c co con cons BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 10 . 1 5 0 0 0 0 1
Copyright © copyright C Co Cop Copy BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 ,-,,, 5 8 0 0 0 0 1
Coburn. This coburn. C Co Cob Cobu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 .- 2 9 0 0 0 0 1
Commons Attribution commons C Co Com Comm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 INITCAP NODIGIT 0 1 1 0 0 0 0 0 11 11 ()., 4 8 0 0 0 0 1
other forums other o ot oth othe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 11 ,() 3 9 0 0 0 0 1
and that and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 11 , 1 10 0 0 0 0 1
academic practice. academic a ac aca acad BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 11 ., 2 9 0 0 0 0 1
comply with comply c co com comp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 11 . 1 2 0 0 0 0 1

